Acetogenins as selective inhibitors of the human ovarian 1A9 tumor cell line

Area of Science:

• Natural product chemistry
• Cancer biology
• Pharmacology

Background:

• Acetogenins are a class of compounds found in plants with known biological activities.
• Ovarian cancer remains a significant health challenge with a need for more effective therapies.
• Selective cancer cell targeting is crucial to minimize side effects.

Purpose of the Study:

• To investigate the potential of bioactive acetogenins as selective inhibitors of ovarian cancer cell replication.
• To identify and characterize the most potent acetogenin against ovarian cancer cells.

Main Methods:

• Screening of several bioactive acetogenins against the 1A9 ovarian cancer cell line.
• Comparative analysis of compound activity against other non-ovarian cancer cell lines.
• Determination of the inhibitory potency (ED50) of the most active compound.

Main Results:

• Several acetogenins demonstrated selective inhibition of 1A9 ovarian cancer cell replication.
• The compound identified as 26, molvizarin, exhibited exceptional selectivity.
• Molvizarin showed over a million-fold greater potency against 1A9 cells compared to other cell lines, with an ED50 of 5 pg/mL.

Conclusions:

• Bioactive acetogenins, particularly molvizarin, represent a promising new class of selective agents for ovarian cancer treatment.
• The high selectivity of molvizarin suggests a favorable therapeutic index and reduced potential for off-target toxicity.
• Further research into molvizarin and related acetogenins is warranted for drug development.